Interestingly, treatment of cancer cells with Pep2–A2 activated autophagic signalling and flux (Fig. 7f,g and Supplementary Movies 7–9), suggesting that Pep2–A2 is an autophagy-inducing peptide through interrupting the TRB3/P62 interaction. This evidence concerns the gene TRIB3 and cancer.